Marc Trudeau

507 total citations
15 papers, 285 citations indexed

About

Marc Trudeau is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc Trudeau has authored 15 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc Trudeau's work include Radiopharmaceutical Chemistry and Applications (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Cancer survivorship and care (3 papers). Marc Trudeau is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Cancer survivorship and care (3 papers). Marc Trudeau collaborates with scholars based in Canada and United States. Marc Trudeau's co-authors include Jeff K. Vallance, Nicole Culos-Reed, Carolyn Freeman, Brenda Clark, Luís Souhami, Robert J. Seymour, Ted N. Roman, G. Stanimir, Camille Granvil and Julie Ducharme and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Marc Trudeau

14 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Trudeau Canada 9 142 73 67 55 45 15 285
Gülten Oskay-Özcelik Germany 11 122 0.9× 37 0.5× 63 0.9× 11 0.2× 82 1.8× 32 352
Micael Lopez-Acevedo United States 11 169 1.2× 122 1.7× 41 0.6× 115 2.1× 227 5.0× 17 626
Αnastasia Bothou Greece 7 71 0.5× 80 1.1× 35 0.5× 28 0.5× 112 2.5× 53 368
A Kurkure India 9 243 1.7× 32 0.4× 42 0.6× 11 0.2× 41 0.9× 13 426
Eduardo Paulino Brazil 11 89 0.6× 66 0.9× 28 0.4× 13 0.2× 71 1.6× 33 291
F. Ghaemmaghami Iran 10 186 1.3× 67 0.9× 71 1.1× 68 1.2× 22 0.5× 23 353
Jessie Ehrisman United States 15 92 0.6× 176 2.4× 79 1.2× 41 0.7× 45 1.0× 27 460
Maria Margarete Karsten Germany 14 189 1.3× 25 0.3× 82 1.2× 16 0.3× 107 2.4× 44 449
Mary D. Chamberlin United States 10 260 1.8× 19 0.3× 46 0.7× 21 0.4× 83 1.8× 39 469
Neil T. Phippen United States 11 85 0.6× 71 1.0× 46 0.7× 27 0.5× 68 1.5× 30 286

Countries citing papers authored by Marc Trudeau

Since Specialization
Citations

This map shows the geographic impact of Marc Trudeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Trudeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Trudeau more than expected).

Fields of papers citing papers by Marc Trudeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Trudeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Trudeau. The network helps show where Marc Trudeau may publish in the future.

Co-authorship network of co-authors of Marc Trudeau

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Trudeau. A scholar is included among the top collaborators of Marc Trudeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Trudeau. Marc Trudeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Basik, Mark, et al.. (2020). Sequential use of Antibiotics and Adjuvant Chemotherapy Leading to a Fatal Pseudomembranous Colitis. SHILAP Revista de lepidopterología. 3(2).
2.
Parimi, Sunil, Misha Eliasziw, Scott North, et al.. (2016). Sunitinib maintenance therapy after response to docetaxel in metastatic castration resistant prostate cancer (mCRPC). Investigational New Drugs. 34(6). 771–776. 3 indexed citations
3.
Vallance, Jeff K., et al.. (2012). Predictors of physical activity among rural and small town breast cancer survivors: An application of the theory of planned behaviour. Psychology Health & Medicine. 17(6). 685–697. 21 indexed citations
4.
Vallance, Jeff K., et al.. (2012). Rural and Small Town Breast Cancer Survivors’ Preferences for Physical Activity. International Journal of Behavioral Medicine. 20(4). 522–528. 36 indexed citations
5.
Vallance, Jeff K., et al.. (2011). Physical activity is associated with clinically important differences in health-related quality of life among rural and small-town breast cancer survivors. Supportive Care in Cancer. 20(5). 1079–1087. 19 indexed citations
6.
O’Callaghan, Chris J., Christos S. Karapetis, H. Au, et al.. (2011). The relationship between the development of rash and clinical and health-related quality of life outcomes by KRAS mutation status in patients with colorectal cancer treated with cetuximab in NCIC CTG CO.17.. Journal of Clinical Oncology. 29(15_suppl). 3588–3588. 6 indexed citations
7.
Eigl, Bernhard J., Marc Trudeau, Eric Winquist, et al.. (2011). A phase II study of sunitinib (SU) for maintenance therapy in metastatic castration-resistant prostate cancer (mCRPC) after response to docetaxel (D).. Journal of Clinical Oncology. 29(7_suppl). 151–151. 3 indexed citations
8.
9.
10.
Trudeau, Marc, Gavin Stuart, Hal W. Hirte, et al.. (2002). A Phase II Trial of JM-216 in Cervical Cancer: An NCIC CTG Study. Gynecologic Oncology. 84(2). 327–331. 21 indexed citations
11.
Warner, Ellen, David W. Hedley, Irene L. Andrulis, et al.. (1998). Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen.. PubMed. 4(6). 1451–7. 38 indexed citations
12.
Trudeau, Marc, et al.. (1998). The Economic Impact of University Research.. 2(3). 8 indexed citations
13.
Granvil, Camille, Julie Ducharme, Brian Leyland‐Jones, Marc Trudeau, & Irving W. Wainer. (1996). Stereoselective pharmacokinetics of ifosfamide and its 2- and 3-N-dechloroethylated metabolites in female cancer patients. Cancer Chemotherapy and Pharmacology. 37(5). 451–456. 19 indexed citations
14.
Souhami, Luís, Robert J. Seymour, Ted N. Roman, et al.. (1993). Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. International Journal of Radiation Oncology*Biology*Physics. 27(4). 871–878. 74 indexed citations
15.
Souhami, Luís, Robert S. Seymour, Ted N. Roman, et al.. (1992). Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. International Journal of Radiation Oncology*Biology*Physics. 24. 165–166. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gülten Oskay-Özcelik Breakdown of academic impact, for papers by Micael Lopez-Acevedo Breakdown of academic impact, for papers by Αnastasia Bothou Breakdown of academic impact, for papers by A Kurkure Breakdown of academic impact, for papers by Eduardo Paulino Breakdown of academic impact, for papers by F. Ghaemmaghami Breakdown of academic impact, for papers by Jessie Ehrisman Breakdown of academic impact, for papers by Maria Margarete Karsten Breakdown of academic impact, for papers by Mary D. Chamberlin Breakdown of academic impact, for papers by Neil T. Phippen
Rankless by CCL
2026